Bulletin
Investor Alert

New York Markets After Hours

ALX Oncology Holdings Inc.

NAS: ALXO

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 16, 2022, 4:01 p.m.

/zigman2/quotes/219511930/composite

$

9.58

Change

0.00 0.00%

Volume

Volume 4,712

Quotes are delayed by 20 min

/zigman2/quotes/219511930/composite

Today's close

$ 9.66

$ 9.58

Change

-0.08 -0.83%

Day low

Day high

$9.47

$10.19

Open

52 week low

52 week high

$8.31

$81.19

Open

Company Description

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indicati...

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company's predecessor was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in Burlingame, CA.

Valuation

Price to Book Ratio

2.40

Enterprise Value to EBITDA

-0.41

Efficiency

Liquidity

Current Ratio

24.00

Quick Ratio

24.00

Cash Ratio

23.78

Profitability

Return on Assets

-20.45

Return on Equity

-21.05

Return on Total Capital

-19.83

Capital Structure

Total Debt to Total Assets

0.68

Officers and Executives

Name Age Officer Since Title
Dr. Jaume Pons 54 2015 President, Chief Executive Officer & Director
Dr. Michael Chang - 2015 Vice President-Operations
Mr. Peter S. García 58 2020 Chief Financial Officer
Dr. Sophia Randolph 52 2016 Chief Medical Officer
Mr. Hank Stern - 2015 Vice President-Chemistry, Manufacturing & Controls

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/07/2022 Peter S. García
Chief Financial Officer
8,363   Derivative/Non-derivative trans. at $4.81 per share. 40,226
02/07/2022 Peter S. García
Chief Financial Officer
6,637   Derivative/Non-derivative trans. at $4.08 per share. 27,078
02/03/2022 Jaume Pons
President & CEO; Director
12,254   Derivative/Non-derivative trans. at $1.91 per share. 23,405
02/03/2022 Jaume Pons
President & CEO; Director
11,900   Derivative/Non-derivative trans. at $0.99 per share. 11,781
01/28/2022 Shelly Pinto
VP, Finance and CAO
50,000   Award at $0 per share. 0
12/15/2021 Sophia Randolph
Chief Medical Officer; Director
11,059   Derivative/Non-derivative trans. at $1.91 per share. 21,122
12/15/2021 Sophia Randolph
Chief Medical Officer; Director
12,793   Derivative/Non-derivative trans. at $0.99 per share. 12,665
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
60   Disposition at $30.23 per share. 1,813
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
440   Disposition at $30.23 per share. 13,301
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
181   Disposition at $29.6 per share. 5,357
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,329   Disposition at $29.6 per share. 39,338
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
299   Disposition at $28.37 per share. 8,482
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
2,196   Disposition at $28.37 per share. 62,300
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,296   Disposition at $27.49 per share. 35,627
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
9,509   Disposition at $27.49 per share. 261,402
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
2,339   Disposition at $26.48 per share. 61,936
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
17,169   Disposition at $26.48 per share. 454,635
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,627   Disposition at $25.29 per share. 41,146
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
11,945   Disposition at $25.29 per share. 302,089
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
60   Disposition at $30.23 per share. 1,813
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
440   Disposition at $30.23 per share. 13,301
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
181   Disposition at $29.6 per share. 5,357
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,329   Disposition at $29.6 per share. 39,338
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
299   Disposition at $28.37 per share. 8,482
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
2,196   Disposition at $28.37 per share. 62,300
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,296   Disposition at $27.49 per share. 35,627
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
286,496   Disposition at $27.49 per share. 7,875,775
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
2,339   Disposition at $26.48 per share. 61,936
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
17,169   Disposition at $26.48 per share. 454,635
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,627   Disposition at $25.29 per share. 41,146
12/13/2021 LSV CAPITAL MANAGEMENT LLC
Director
11,945   Disposition at $25.29 per share. 302,089
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
12   Disposition at $32.16 per share. 385
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
88   Disposition at $32.16 per share. 2,830
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
2,172   Disposition at $31.55 per share. 68,526
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
15,942   Disposition at $31.55 per share. 502,970
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
967   Disposition at $30.77 per share. 29,754
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
7,093   Disposition at $30.77 per share. 218,251
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
12   Disposition at $32.16 per share. 385
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
88   Disposition at $32.16 per share. 2,830
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
2,172   Disposition at $31.55 per share. 68,526
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
15,942   Disposition at $31.55 per share. 502,970
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
967   Disposition at $30.77 per share. 29,754
12/10/2021 LSV CAPITAL MANAGEMENT LLC
Director
7,093   Disposition at $30.77 per share. 218,251
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,911   Disposition at $32.73 per share. 62,547
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
14,028   Disposition at $32.73 per share. 459,136
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
5,751   Disposition at $32.06 per share. 184,377
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
42,203   Disposition at $32.06 per share. 1,353,028
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,560   Disposition at $31.08 per share. 48,484
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
11,452   Disposition at $31.08 per share. 355,928
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,911   Disposition at $32.73 per share. 62,547
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
14,028   Disposition at $32.73 per share. 459,136
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
5,751   Disposition at $32.06 per share. 184,377
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
42,203   Disposition at $32.06 per share. 1,353,028
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,560   Disposition at $31.08 per share. 48,484
12/09/2021 LSV CAPITAL MANAGEMENT LLC
Director
11,452   Disposition at $31.08 per share. 355,928
12/08/2021 LSV CAPITAL MANAGEMENT LLC
Director
208   Disposition at $33.8 per share. 7,030
12/08/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,531   Disposition at $33.8 per share. 51,747
12/08/2021 LSV CAPITAL MANAGEMENT LLC
Director
4,883   Disposition at $33.23 per share. 162,262
12/08/2021 LSV CAPITAL MANAGEMENT LLC
Director
35,836   Disposition at $33.23 per share. 1,190,830
12/08/2021 LSV CAPITAL MANAGEMENT LLC
Director
208   Disposition at $33.8 per share. 7,030
12/08/2021 LSV CAPITAL MANAGEMENT LLC
Director
1,531   Disposition at $33.8 per share. 51,747
12/08/2021 LSV CAPITAL MANAGEMENT LLC
Director
4,883   Disposition at $33.23 per share. 162,262
12/08/2021 LSV CAPITAL MANAGEMENT LLC
Director
35,836   Disposition at $33.23 per share. 1,190,830
11/22/2021 Sophia Randolph
Chief Medical Officer; Director
14,884   Disposition at $36.77 per share. 547,284
11/22/2021 Sophia Randolph
Chief Medical Officer; Director
30,000   Derivative/Non-derivative trans. at $4.08 per share. 122,400
10/18/2021 Peter S. García
Chief Financial Officer
189   Disposition at $59.06 per share. 11,162
10/18/2021 Peter S. García
Chief Financial Officer
438   Disposition at $58.3 per share. 25,535
10/18/2021 Peter S. García
Chief Financial Officer
411   Disposition at $57.54 per share. 23,648
10/18/2021 Peter S. García
Chief Financial Officer
1,437   Disposition at $56.09 per share. 80,601
10/18/2021 Peter S. García
Chief Financial Officer
1,903   Disposition at $55.15 per share. 104,950
10/18/2021 Peter S. García
Chief Financial Officer
2,851   Disposition at $54.33 per share. 154,894
10/18/2021 Peter S. García
Chief Financial Officer
7,229   Derivative/Non-derivative trans. at $4.08 per share. 29,494
/news/latest/company/us/alxo

MarketWatch News on ALXO

  1. ALX Oncology stock price target cut to $36 from $60 at Stifel Nicolaus

    8:40 a.m. March 1, 2022

    - Tomi Kilgore

  2. ALX Oncology initiated at buy with $106 target price at Stifel

    7:04 a.m. Sept. 30, 2021

    - Tonya Garcia

  3. ALX Oncology started at buy with $96 stock price target at UBS

    8:51 a.m. April 6, 2021

    - Tomi Kilgore

  4. Biotech stocks are a buy — especially these 18 picks

    2:02 p.m. March 13, 2021

    - Michael Brush

  5. ALX Oncology sets IPO terms, to raise up to $136 million

    8:29 a.m. July 13, 2020

    - Tomi Kilgore

/news/nonmarketwatch/company/us/alxo

Other News on ALXO

  1. ALX Oncology files for $450 mixed shelf offering

    5:32 p.m. March 25, 2022

    - Seeking Alpha

  2. 10-K: ALX ONCOLOGY HOLDINGS INC

    9:00 a.m. Feb. 28, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  3. ALX Oncology Is Turning Into An Also-Ran In Anti-CD47

    8:27 a.m. Feb. 15, 2022

    - Seeking Alpha

  4. New Strong Sell Stocks for January 19th

    7:23 a.m. Jan. 19, 2022

    - Zacks.com

  5. ALX Oncology plunges as director sells shares worth $75M

    3:31 p.m. Dec. 16, 2021

    - Seeking Alpha

  6. RENN, VIOT and IGMS among mid-day movers

    1:31 p.m. Dec. 13, 2021

    - Seeking Alpha

  7. ALX Oncology Holdings (ALXO) Investor Presentation

    2:21 p.m. Nov. 23, 2021

    - Seeking Alpha

  8. 10-Q: ALX ONCOLOGY HOLDINGS INC

    9:44 a.m. Nov. 12, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  9. Warning: ALXO is at high risk of performing badly

    5:52 a.m. Nov. 11, 2021

    - Seeking Alpha

  10. AGC, QUBT and BTB among mid-day movers

    1:48 p.m. Nov. 9, 2021

    - Seeking Alpha

  11. JP, HCDI and PETZ among mid-day movers

    1:48 p.m. Nov. 4, 2021

    - Seeking Alpha

  12. Loading more headlines...

At a Glance

ALX Oncology Holdings, Inc.

323 Allerton Avenue

South San Francisco, California 94080

Phone

1 6504667125

Industry

Pharmaceuticals

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

Revenue

N/A

Net Income

$-83.46M

Employees

43.00

/news/pressrelease/company/us/alxo

Press Releases on ALXO

  1. Loading more headlines...
Link to MarketWatch's Slice.